-
Subject Areas on Research
-
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
-
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
-
A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
-
A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation: first animal trial.
-
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
-
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
-
AIM-AF: A Physician Survey in the United States and Europe.
-
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
-
Action potential and QT prolongation not sufficient to cause Torsade de Pointes: role of action potential triangulation.
-
Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS.
-
Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.
-
After myocardial infarction. How to determine future risk and what to do then.
-
Amiodarone and reperfusion ventricular fibrillation.
-
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.
-
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
-
Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study.
-
Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
-
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
-
An adverse reaction to a medication given to treat an adverse reaction: a teachable moment.
-
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
-
Anesthetic induction with fentanyl and intravenous lidocaine for coronary artery surgery.
-
Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
-
Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.
-
Antiarrhythmic agents in older patients. Current state of knowledge.
-
Antiarrhythmic drug action. Blockade of the inward sodium current.
-
Antiarrhythmic drug action: selective depression of hypoxic cardiac cells.
-
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
-
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
-
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).
-
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators.
-
Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
-
Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada.
-
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.
-
Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
-
Atrial fibrillation ablation in practice: assessing CABANA generalizability.
-
Atrial fibrillation in heart failure: what should we do?
-
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
-
Atrial fibrillation: conventional wisdom reappraised.
-
Atrial fibrillation: rate control versus maintenance of sinus rhythm.
-
Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
-
Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing.
-
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial.
-
Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs.
-
Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.
-
Block and modulation of cardiac Na+ channels by antiarrhythmic drugs, neurotransmitters and hormones.
-
Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.
-
CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial.
-
CASE 6--2012: suspected amiodarone hepatotoxicity after cardiac surgery.
-
CE coupling with end-column electrochemiluminescence detection for chiral separation of disopyramide.
-
Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?
-
Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
-
Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration.
-
Cardioversion and subsequent quality of life and natural history of atrial fibrillation.
-
Cases from the Osler Medical Service at Johns Hopkins University. Digitalis toxicity with bidirectional ventricular tachycardia.
-
Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply.
-
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
-
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.
-
Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
-
Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers.
-
Changes in atrioventricular conduction properties with refractory-period modulation.
-
Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias.
-
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
-
Clinical application of cardiovascular pharmacogenetics.
-
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
-
Combination ethacizin and ethmozin treatment of resistant ventricular ectopy: theoretical, experimental, and clinical study.
-
Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation.
-
Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants.
-
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery.
-
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
-
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
-
Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias.
-
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
-
Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
-
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?
-
Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series.
-
Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias.
-
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
-
Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.
-
Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.
-
Cryoablation for atrial fibrillation and antiarrhythmic drug pretreatment: a single referral center experience.
-
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
-
Current and novel pharmacologic approaches in advanced heart failure.
-
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator.
-
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
-
Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias.
-
Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia.
-
Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.
-
Digoxin and Mortality in Patients With Atrial Fibrillation.
-
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
-
Distributed decision support using a web-based interface: prevention of sudden cardiac death.
-
Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials.
-
Dofetilide dose reductions and discontinuations in women compared with men.
-
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.
-
Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
-
Dronedarone in high-risk permanent atrial fibrillation.
-
Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.
-
Drug-drug interactions in older adults: which ones matter?
-
Early experience with intravenous sotalol in children with and without congenital heart disease.
-
Early management of atrial fibrillation to prevent cardiovascular complications.
-
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
-
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
-
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
-
Effect of amiodarone-induced hyperthyroidism on left ventricular outflow obstruction after septal myectomy for hypertrophic cardiomyopathy.
-
Effect of dofetilide on survival in patients with supraventricular arrhythmias.
-
Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial.
-
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
-
Effects of ZD6169, a K ATP channel opener, on neurally-mediated plasma extravasation in the rat urinary bladder induced by chemical or electrical stimulation of nerves.
-
Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
-
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
-
Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.
-
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
-
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
-
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.
-
Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids.
-
Emerging class III antiarrhythmic agents: mechanism of action and proarrhythmic potential.
-
Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
-
Ethacizin blockade of calcium channels: a test of the guarded receptor hypothesis.
-
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).
-
Experience with moricizine HCl in children with supraventricular tachycardia.
-
Exploring the role of pH in modulating the effects of lidocaine in virtual ischemic tissue.
-
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
-
Frequency of high-risk use of QT-prolonging medications.
-
Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age.
-
Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.
-
Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
-
Heart Failure and Atrial Fibrillation, Like Fire and Fury.
-
Hemodynamic effects of the antiarrhythmic drug pirmenol.
-
Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana.
-
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project.
-
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.
-
In-hospital management of patients with atrial flutter.
-
Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
-
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF).
-
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
-
Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.
-
Insights into the contemporary epidemiology and outpatient management of congestive heart failure.
-
Intentional and unintentional medication non-adherence in African Americans: Insights from the Jackson Heart Study.
-
Interaction between digoxin and dronedarone in the PALLAS trial.
-
Interpreting the Results of Intention-to-Treat, Per-Protocol, and As-Treated Analyses of Clinical Trials.
-
Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery.
-
Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
-
Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
-
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
-
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
-
Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
-
Left atrial tachycardia originating from the mitral annulus-aorta junction.
-
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
-
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
-
Long-term oral anticoagulant after catheter ablation for atrial fibrillation.
-
Loss of efficacy during long-term cifenline therapy: development of antiarrhythmic resistance?
-
MADIT-II: clinical implications.
-
Magnesium supplementation during cardiopulmonary bypass to prevent junctional ectopic tachycardia after pediatric cardiac surgery: a randomized controlled study.
-
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
-
Management of pediatric tachyarrhythmias on mechanical support.
-
Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry.
-
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
-
Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination.
-
Mechanisms of apparent affinity variation of guarded receptors.
-
Mechanisms of atrial fibrillation and action of drugs used in its management.
-
Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.
-
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.
-
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
-
Models of drug interaction with the sodium channel.
-
Modulating intraventricular conduction through competition of two class 1 antiarrhythmic agents: experience with ethacizin and lidocaine in canine heart.
-
Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification.
-
Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
-
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction.
-
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance.
-
New drug application strategies for supraventricular arrhythmias.
-
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
-
Obstructive sleep apnea is associated with increased rotor burden in patients undergoing focal impulse and rotor modification guided atrial fibrillation ablation.
-
On the mechanism of action of antiarrhythmic agents.
-
Ongoing Management of Patients With Supraventricular Tachycardia.
-
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
-
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.
-
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.
-
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
-
Patterns of Care for Atrial Fibrillation Before, During, and at Discharge From Hospitalization: From the Get With The Guidelines-Atrial Fibrillation Registry.
-
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
-
Pediatric electrophysiology.
-
Perioperative Management of Flecainide: A Problem-Based Learning Discussion.
-
Perioperative cardiac arrhythmias.
-
Pharmacokinetic and tolerance evaluation of actisomide, a new antiarrhythmic agent, in healthy volunteers.
-
Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
-
Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions.
-
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
-
Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.
-
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
-
Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
-
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
-
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
-
Prehospital amiodarone may increase the incidence of acute respiratory distress syndrome among patients at risk.
-
Prevention of sudden death in patients with coronary artery disease.
-
Previously unreported adverse reaction to encainide.
-
Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
-
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
-
Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.
-
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.
-
Propafenone-induced acute generalized exanthematous pustulosis.
-
Propafenone: an effective agent for the management of supraventricular arrhythmias.
-
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
-
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
-
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.
-
Publishing web-based guidelines using interactive decision models.
-
Pulmonary edema post-cardioversion: a potential calcium signalling problem.
-
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials.
-
Quality of life in patients with implantable cardioverter-defibrillator: systematic review of randomized controlled trials.
-
Quality of life with defibrillator therapy or amiodarone in heart failure.
-
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
-
Ranolazine reduces atrial fibrillatory wave frequency.
-
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
-
Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
-
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
-
Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review.
-
Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study.
-
Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
-
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
-
Regional anesthesia for thyroidectomy in two patients with amiodarone-induced hyperthyroidism.
-
Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
-
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
-
Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report.
-
Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report.
-
Review: In noncardiac surgery, amiodarone, β-blocker, or statin prophylaxis reduces postoperative AF.
-
Rhythm control in atrial fibrillation.
-
Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation.
-
Rhythm control versus rate control for atrial fibrillation and heart failure.
-
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
-
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
-
Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
-
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
-
Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision.
-
Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998.
-
Several new considerations in mitral valve repair.
-
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
-
Sinus node dysfunction.
-
Slow sodium channel inactivation and use-dependent block modulated by the same domain IV S6 residue.
-
State dependence of ethacizin and ethmozin block of sodium current in voltage clamped and internally perfused cardiac Purkinje cells.
-
Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
-
Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program).
-
Supraventricular tachycardia in four young dogs.
-
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials.
-
Surrogate end points in heart failure trials.
-
Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia.
-
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
-
The cardiac sodium channel: a target for antiarrhythmic drug action.
-
The effect of bretylium tosylate on ventricular function.
-
The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
-
The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.
-
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
-
The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.
-
Thyroid function in heart failure and impact on mortality.
-
To be or not to be in normal sinus rhythm: what do we really know?
-
Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.
-
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging Substudy.
-
Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest.
-
Update on sick sinus syndrome, a cardiac disorder of aging.
-
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.
-
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
-
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.
-
Use of implantable cardioverter defibrillator and anti-arrhythmic agents in a parturient.
-
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
-
Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect.
-
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.
-
Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating high-frequency fibrillatory-like arrhythmias.
-
What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.
-
When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism.
-
Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial.
-
[The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation].
-
Keywords of People
-
-
Alexander, John Hunter Peel,
Professor of Medicine,
Medicine, Cardiology
-
Curtis, Lesley H.,
Professor in Population Health Sciences,
Medicine, General Internal Medicine
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology
-
Pitt, Geoffrey Stuart,
Adjunct Professor in the Department of Medicine,
Medicine, Cardiology
-
Starmer, Charles Franklin,
Professor Emeritus of Computer Science,
Computer Science